These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3770068)

  • 1. To nurse when receiving acebutolol: is it dangerous for the neonate?
    Boutroy MJ; Bianchetti G; Dubruc C; Vert P; Morselli PL
    Eur J Clin Pharmacol; 1986; 30(6):737-9. PubMed ID: 3770068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].
    Kukes VG; Gneushev ET; Mamedov TSh; Gneusheva IA
    Farmakol Toksikol; 1991; 54(1):53-5. PubMed ID: 1860501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
    Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
    J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acebutolol: ten years of experience.
    De Bono G; Kaye CM; Roland E; Summers AJ
    Am Heart J; 1985 May; 109(5 Pt 2):1211-3. PubMed ID: 2859785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
    Abernethy DR; Arendt RM; Greenblatt DJ
    Am Heart J; 1985 May; 109(5 Pt 2):1120-5. PubMed ID: 2859774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
    Ohashi K; Warrington SJ; Kaye CM; Houghton GW; Dennis M; Templeton R; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):561-5. PubMed ID: 7295489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
    Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
    Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man.
    Borchard U; Hafner D; Hirth C
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):4-17. PubMed ID: 2860878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol.
    Basil B; Jordan R
    Eur J Pharmacol; 1982 May; 80(1):47-56. PubMed ID: 6124437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
    Szymura-Oleksiak J; Walczak M; Bojarski J; Aboul-Enein HY
    Chirality; 1999; 11(4):267-71. PubMed ID: 10224653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
    Sankey MG; Gulaid A; Kaye CM
    J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acebutolol and coronary artery surgery. Plasma levels following oral pre-operative treatment.
    Thoms GM; Reece IJ; Odom NJ; Kaye CM; Sankey MG
    Anaesthesia; 1982 Nov; 37(11):1078-83. PubMed ID: 6982635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effect of diacetolol in essential hypertension.
    Thibonnier M; Flabeau C; Thouvenin M; Roux A; Flouvat B; Pasquier P; Menard J
    Br J Clin Pharmacol; 1982 Apr; 13(4):533-7. PubMed ID: 6121577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
    Zaman R; Jack DB; Wilkins MR; Kendall MJ
    Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS; Burm JP
    Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
    Singh BN; Thoden WR; Ward A
    Drugs; 1985 Jun; 29(6):531-69. PubMed ID: 3891306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal effects of maternal administration of acebutolol.
    Dumez Y; Tchobroutsky C; Hornych H; Amiel-Tison C
    Br Med J (Clin Res Ed); 1981 Oct; 283(6299):1077-9. PubMed ID: 6794766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.